Serum S-100B and cleaved-tau are poor predictors of long-term outcome after mild traumatic brain injury

References

• Jager TE, Weiss HB, Coben JH, Pepe PE. Traumatic brain injuries evaluated in U.S. emergency departments, 1992–1994. Academic Emergency Medicine 2000; 7: 134–140
   PubMed Web of Science ®Google Scholar
• Bazarian JJ, Wong T, Harris M, Leahey N, Mookerjee S, Dombovy M. Epidemiology and predictors of post-concussive syndrome after minor head injury in an emergency population. Brain Injury 1999; 13: 173–189
   PubMed Web of Science ®Google Scholar
• Kraus J, Schaffer K, Ayers K, Stenehjem J, Shen H, Afifi AA. Physical complaints, medical service use, and social and employment changes following mild traumatic brain injury: A 6-month longitudinal study. Journal of Head Trauma Rehabilitation 2005; 20: 239–256
   PubMed Web of Science ®Google Scholar
• Jagoda AS, Cantrill SV, Wears RL, Valadka A, Gallagher EJ, Gottesfeld SH, Pietrzak MP, Bolden J, Burns JJ, Zimmerman R. Clinical policy: Neuroimaging and decision-making in adult mild traumatic brain injury in the acute setting. Annals of Emergency Medicine 2002; 40: 231–249
   PubMedGoogle Scholar
• Ingebrigtsen T, Romner B, Marup-Jensen S, Dons M, Lundqvist C, Bellner J, Alling C, Borgesen SE. The clinical value of serum S-100 protein measurements in minor head injury: A Scandinavian multicentre study. Brain Injury 2000; 14: 1047–1055
   PubMed Web of Science ®Google Scholar
• Romner B, Ingebrigtsen T, Kongstad P, Borgesen SE. Traumatic brain damage: Serum S-100 protein measurements related to neuroradiological findings. Journal of Neurotrauma 2000; 17: 641–647
   PubMed Web of Science ®Google Scholar
• Biberthaler P, Mussack T, Wiedemann E, Kanz KG, Koelsch M, Gippner-Steppert C, Jochum M. Evaluation of S-100b as a specific marker for neuronal damage due to minor head trauma. World Journal of Surgery 2001; 25: 93–97
   PubMed Web of Science ®Google Scholar
• Biberthaler P, Mussack T, Kanz KG, Lisenmaier V, Pfeifer K-J, Mutschler W, Jochum M. Identifikation von Hochrisiko-patienten nach leightem Schadel-Hirn-Trauma: Messung des neurogalialen Proteins S100. Unfallchirurg 2004; 170: 197–202
   Google Scholar
• Waterloo K, Ingebrigtsen T, Romner B. Neuropsychological function in patients with increased serum levels of protein S-100 after minor head injury. Acta Neurochirurgica 1997; 139: 26–31, discussion 31–22
   PubMed Web of Science ®Google Scholar
• Ingebrigtsen T, Waterloo K, Jacobsen EA, Langbakk B, Romner B. Traumatic brain damage in minor head injury: Relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome. Neurosurgery 1999; 45: 468–475, discussion 475–466
   PubMed Web of Science ®Google Scholar
• Herrmann M, Curio N, Jost S, Grubich C, Ebert AD, Fork ML, Synowitz H. Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neurophsychological outcome after traumatic brain injury. Journal of Neurology, Neurosurgery & Psychiatry 2001; 70: 95–100
   PubMed Web of Science ®Google Scholar
• McAllister TW, Saykin AJ, Flashman LA, Sparling MB, Johnson SC, Guerin SJ, Mamourian AC, Weaver JB, Yanofsky N. Brain activation during working memory 1 month after mild traumatic brain injury: A functional MRI study. Neurology 1999; 53: 1300–1308
   PubMed Web of Science ®Google Scholar
• Ingebrigtsen T, Romner B, Kongstad P, Langbakk B. Increased serum concentrations of protein S-100 after minor head injury: A biochemical serum marker with prognostic value?. Journal of Neurology, Neurosurgery & Psychiatry 1995; 59: 103–104
   PubMed Web of Science ®Google Scholar
• De Kruijk JR, Leffers P, Menheere PP, Meerhoff S, Rutten J, Twijnstra A. Prediction of post-traumatic complaints after mild traumatic brain injury: Early symptoms and biochemical markers. Journal of Neurology, Neurosurgery & Psychiatry 2002; 73: 727–732
   PubMed Web of Science ®Google Scholar
• Thurman DJ, Guerrero JL. Trends in hospitalization associated with traumatic brain injury. Journal of the American Medical Association 1999; 282: 954–957
   PubMed Web of Science ®Google Scholar
• Mao Q, Chen J, Li N, Li C, Mao B, Wang R, Wu G. [The value of serum myelin basic protein in assessment of severity of acute closed head trauma]. Hua-Hsi i Ko Ta Hsueh Hsueh Pao. [Journal of West China University of Medical Sciences] 1995; 26: 135–137
   Google Scholar
• Yamazaki Y, Yada K, Morii S, Kitahara T, Ohwada T. Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury. Surgical Neurology 1995; 43: 267–270, discussion 270–261
   PubMed Web of Science ®Google Scholar
• Zemlan FP, Jauch EC, Mulchahey JJ, et al. C-tau biomarker of neuronal damage in severe brain injured patients: Association with elevated intracranial pressure and clinical outcome. Brain Research 2002; 947: 131–139
   PubMed Web of Science ®Google Scholar
• Zemlan FP, Rosenberg WS, Luebbe PA, Campbell TA, Dean GE, Weiner NE, Cohen JA, Rudick RA, Woo D. Quantification of axonal damage in traumatic brain injury: Affinity purification and characterization of cerebrospinal fluid tau proteins. Journal of Neurochemistry 1999; 72: 741–750
   PubMed Web of Science ®Google Scholar
• Shaw GJ, Jauch EC, Zemlan FP. Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury [comment]. Annals of Emergency Medicine 2002; 39: 254–257
   PubMed Web of Science ®Google Scholar
• Kay T, Harrington DE, Adams R, Anderson T, Berrol S, Cicerione K, Dahlberg C, Gerber D, Goka R, Harley P, et al. Definition of mild traumatic brain injury. Journal of Head Trauma Rehabilitation 1993; 8: 86–87
   Google Scholar
• Jackson RG, Samra GS, Radcliffe J, Clark GH, Price CP. The early fall in levels of S-100 beta in traumatic brain injury. Clinical Chemistry & Laboratory Medicine 2000; 38: 1165–1167
   PubMed Web of Science ®Google Scholar
• Adami C, Sorci G, Blasi E, Agneletti AL, Bistoni F, Donato R. S100B expression in and effects on microglia. Glia 2001; 33: 131–142
   PubMed Web of Science ®Google Scholar
• Wiesmann M, Wandinger KP, Missler U, Eckhoff D, Rothermundt M, Arolt V, Kirchner H. Elevated plasma levels of S-100b protein in schizophrenic patients. Biological Psychiatry 1999; 45: 1508–1511
   PubMed Web of Science ®Google Scholar
• Otto M, Holthusen S, Bahn E, Sohnchen N, Wiltfang J, Geese R, Fischer A, Reimers CD. Boxing and running lead to a rise in serum levels of S-100B protein. International Journal of Sports Medicine 2000; 21: 551–555
   PubMed Web of Science ®Google Scholar
• Stiell IG, Wells GA, Vandemheen K, Clement C, Lesiuk H, Laupacis A, McKnight RD, Verbeek R, Brison R, Cass D, et al. The Canadian CT Head Rule for patients with minor head injury [comment]. Lancet 2001; 357: 1391–1396
   PubMed Web of Science ®Google Scholar
• King NS, Crawford S, Wenden FJ, Moss NE, Wade DT. The Rivermead post concussion symptoms questionnaire: A measure of symptoms commonly experienced after head injury and its reliability. Journal of Neurology 1995; 242: 587–592
   PubMed Web of Science ®Google Scholar
• Crawford S, Wenden FJ, Wade DT. The Rivermead head injury follow up questionnaire: A study of a new rating scale and other measures to evaluate outcome after head injury. Journal of Neurology, Neurosurgery & Psychiatry 1996; 60: 510–514
   PubMed Web of Science ®Google Scholar
• Ingebrigtsen T, Waterloo K, Marup-Jensen S, Attner E, Romner B. Quantification of post-concussion symptoms 3 months after minor head injury in 100 consecutive patients. Journal of Neurology 1998; 245: 609–612
   PubMed Web of Science ®Google Scholar
• Ponsford J, Willmott C, Rothwell A, Cameron P, Ayton G, Nelms R, Curran C, Ng K. Impact of early intervention on outcome after mild traumatic brain injury in children. Pediatrics 2001; 108: 1297–1303
   PubMed Web of Science ®Google Scholar
• Wade DT, King NS, Wenden FJ, Crawford S, Caldwell FE. Routine follow up after head injury: A second randomised controlled trial. Journal of Neurology, Neurosurgery & Psychiatry 1998; 65: 177–183
   PubMed Web of Science ®Google Scholar
• Morey CE, Cilo M, Berry J, Cusick C. The effect of Aricept in persons with persistent memory disorder following traumatic brain injury: A pilot study. Brain Injury 2003; 17: 809–815
   PubMed Web of Science ®Google Scholar
• Meythaler JM, Brunner RC, Johnson A, Novack TA. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: A pilot double-blind randomized trial. Journal of Head Trauma Rehabilitation 2002; 17: 300–313
   PubMed Web of Science ®Google Scholar
• Griffin SL, van R, Masanic C. A review of cholinergic agents in the treatment of neurobehavioral deficits following traumatic brain injury. Journal of Neuropsychiatry & Clinical Neurosciences 2003; 15: 17–26
   PubMed Web of Science ®Google Scholar
• Hurley SD, Olschowka JA, O’Banion MK. Cyclooxygenase inhibition as a strategy to ameliorate brain injury. Journal of Neurotrauma 2002; 19: 1–15
   PubMedGoogle Scholar
• Kay T. Neuropsychological diagnosis: Disentangling the multiple determinants of functional disability after mild traumatic brain injury. Physical medicine and rehabilitation: State of the art reviews, L Horn, N Zasler. Philadelphia: Hanley and Belfus Inc. 1992; 109–127
   Google Scholar
• Alves W, Macciocchi SN, Barth JT. Postconcussive symptoms after uncomplicated mild head injury. Journal of Head Trauma Rehabilitation 1993; 8: 48–59
   Google Scholar
• Levin HS, Mattis S, Ruff RM, Eisenberg HM, Marshall LF, Tabaddor K, High WM, Jr, Frankowski RF. Neurobehavioral outcome following minor head injury three center study. Journal of Neurosurgery 1987; 66: 234–243
   PubMed Web of Science ®Google Scholar
• Mittl RL, Grossman RI, Hiehle JF. Prevalence of MR evidence of diffuse axonal injury in patients with mild head injury and normal head CT findings. American Journal of Neuroradiology 1994; 15: 1583–1589
   PubMed Web of Science ®Google Scholar
• Audenaert K, Jansen HML, Otte A, Peremans K, Vervaet M, Crombez R, DeRidder L, Vanheeringen C, Thhirot J, Dierckx R, et al. Imaging of mild traumatic brain injury using 57Co and 99mTc HMPAO SPECT as compared to other diagnostic procedures. Medical Science Monitor 2003; 9: MT112–MT117
   PubMedGoogle Scholar
• Govindaraju V, Gauger GE, Manley GT, Ebel A, Meeker M, Maudsley AA. Volumetric proton spectroscopic imaging of mild traumatic brain injury. American Journal of Neuroradiology 2004; 25: 730–737
   PubMed Web of Science ®Google Scholar
• Reiber H. Proteins in cerebrospinal fluid and blood: Barriers, CSF flow rate and source-related dynamics. Restorative Neurology and Neuroscience 2003; 21: 79–96
   PubMed Web of Science ®Google Scholar
• Kanner AA, Marchi N, Fazio V, Mayberg MR, Michael T, Sioman V, Stevens G, Masaryk T, Ayumar B, Vogelbaum M, et al. Serum S100B; a noninvasive marker of blood–brain barrier function and brain lesions. Cancer (American Cancer Society) 2003; 97: 2806–2813
   PubMed Web of Science ®Google Scholar
• Marchi N, Fazio V, Cucullo L, Knight K, Masaryk T, Barnett G, Vogelbaum M, Kinter M, Rasmussen P, Mayberg MR. Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption. The Journal of Neuroscience 2003; 23: 1949–1955
   PubMed Web of Science ®Google Scholar
• Kapural M, Bengez-Krizanac L, Barnett G, Perl J, Masaryk T, Apollo D, Ramussen P, Mayberg MR, Janigro D. Serum S-100B as a possible marker of blood–brain barrier disruption. Brain Research 2002; 940: 102–104
   PubMed Web of Science ®Google Scholar
• Berger R. Biomarkers or neuroimaging in central nervous system injury: Will the real ‘gold standard’ please stand up?. Pediatric Critical Care Medicine 2003; 4: 391–392
   PubMedGoogle Scholar
• De Kruijk JR, Leffers P, Menheere PP, Meerhoff S, Twijnstra A. S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients. A comparison with health controls. Acta Neurologica Scandinavica 1999; 103: 175–179
   Google Scholar
• Mussack T, Biberthaler P, Wiedemann E, Kanz KG, Englert A, Gippner-Steppert C, Jochum M. S-100b as a screening marker of the severity of minor head trauma (MHT)—a pilot study. Acta Neurochirurgica–Supplement 2000; 76: 393–396
   PubMedGoogle Scholar
• Herrmann M, Jost S, Kutz S, Ebert AD, Kratz T, Wunderlich MT, Synowitz H. Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. Journal of Neurotrauma 2000; 17: 113–122
   PubMed Web of Science ®Google Scholar
• Biberthaler P, Mussack T, Wiedemann E, Gilg T, Soyka M, Koller G, Pfeifer KJ, Linsenmaier U, Mutschler W. Elevated serum levels of S-100B reflect the extent of brain injury in alcohol intoxicated patients after mild head trauma. Shock 2001; 16: 97–101
   PubMed Web of Science ®Google Scholar
• Gunstad J, Suhr JA. Cognitive factors in postconcussion syndrome symptom report. Archives of Clinical Neuropsychology 2004; 19: 391–405
   PubMed Web of Science ®Google Scholar
• McAllister TW, Sparling MB, Flashman LA, Guerin SJ, Mamourian AC, Saykin AJ. Differential working memory load effects after mild traumatic brain injury. NeuroImage 2001; 14: 1004–1012
   PubMed Web of Science ®Google Scholar